Atlas FDA

API ZYM Bx2 (Ref 70493) Product Usage: ZYM B reagent is an additional test used for revealing the results of some miniat

FDA device recall Z-0756-2016 · posted 2016-02-04 · Terminated

Recall details

Recalling firm
BioMerieux SA
Reason for recall
Discrepant identification results related to API identification strips. These discrepant identification results are due to false negative results on the tests of the strips linked to the ZYM B reagent.
Action taken
BioMrieux sent an Urgent Field Safety Notice letter DATED jANUARY 8, 2015 to affected customers. The letter identified the affected product, problem and action to be taken. dated . The letter indicated that they could continue to use product in inventory with mandatory requirements that before using a ZYM B ampule and each day of use of API strips that they perform a quality control with ATCC strains as described in each package insert of involved API strips. The letter also requested that they distribute this letter to all appropriate personnel in the laboratory, retain a copy for their files, and forward the information to all parties that may use the product. For additional assistance or have any questions, contact your local bioMrieux Customer Service representative.
Root cause
Other
Status
Terminated
Product code
LIB
Quantity affected
13,271
Distribution
Nationwide Distribution in the states of: AL, CA, CO, CT, DC, FL, GA, HI, IL, IN, IA, KS, KY, ME, MD, MA, MI, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TX, VT, VA, WA, WV, WI
Date initiated
2016-01-08
Date posted
2016-02-04
Date terminated
2017-07-14
Location
Marcy L'Etoile, France

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.